Weekly Journal Scan: improved renal outcomes by semaglutide in patients with chronic kidney disease and type 2 diabetes in FLOW trial

被引：1
作者：
Pedicino, Daniela [1 ]
Volpe, Massimo [2 ,3 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc Med, Largo A Gemelli 8, I-00168 Rome, Italy
[2] Sapienza Univ Rome, Dept Clin & Mol Med, Via Grottarossa 1035, Rome, Italy
[3] IRCCS San Raffaele Roma, Via Valcannuta 250, Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷 / 38期
关键词：
GLP-1 RECEPTOR AGONISTS; MORTALITY;
D O I：
10.1093/eurheartj/ehae429
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：3910 / 3911
页数：2
相关论文
共 50 条
  • [41] Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial
    Oshima, Megumi
    Neuen, Brendon L.
    Jardine, Meg J.
    Bakris, George
    Edwards, Robert
    Levin, Adeera
    Mahaffey, Kenneth W.
    Neal, Bruce
    Pollock, Carol
    Rosenthal, Norman
    Wada, Takashi
    Wheeler, David C.
    Perkovic, Vlado
    Heerspink, Hiddo J. L.
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (11) : 903 - 914
  • [42] Predictive Risk Models to Identify Patients at High-Risk for Severe Clinical Outcomes With Chronic Kidney Disease and Type 2 Diabetes
    Sheer, Richard
    Nair, Radhika
    Pasquale, Margaret K.
    Evers, Thomas
    Cockrell, Meghan
    Gay, Alain
    Singh, Rakesh
    Schmedt, Niklas
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2022, 13
  • [43] Hypokalemia, Its Contributing Factors and Renal Outcomes in Patients with Chronic Kidney Disease
    Wang, Hsiao-Han
    Hung, Chi-Chih
    Hwang, Daw-Yang
    Kuo, Mei-Chuan
    Chiu, Yi-Wen
    Chang, Jer-Ming
    Tsai, Jer-Chia
    Hwang, Shang-Jyh
    Seifter, Julian L.
    Chen, Hung-Chun
    PLOS ONE, 2013, 8 (07):
  • [44] Biomarkers of rapid chronic kidney disease progression in type 2 diabetes
    Looker, Helen C.
    Colombo, Marco
    Hess, Sibylle
    Brosnan, Mary J.
    Farran, Bassam
    Dalton, R. Neil
    Wong, Max C.
    Turner, Charles
    Palmer, Colin N. A.
    Nogoceke, Everson
    Groop, Leif
    Salomaa, Veikko
    Dunger, David B.
    Agakov, Felix
    McKeigue, Paul M.
    Colhoun, Helen M.
    KIDNEY INTERNATIONAL, 2015, 88 (04) : 888 - 896
  • [45] Plasma endostatin predicts kidney outcomes in patients with type 2 diabetes
    Chauhan, Kinsuk
    Verghese, Divya Anna
    Rao, Veena
    Chan, Lili
    Parikh, Chirag R.
    Coca, Steven G.
    Nadkarni, Girish N.
    KIDNEY INTERNATIONAL, 2019, 95 (02) : 439 - 446
  • [46] Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis
    Koya, Daisuke
    Anker, Stefan D.
    Ruilope, Luis M.
    Rossing, Peter
    Liu, Zhihong
    Lee, Byung Wan
    Lee, Chien-Te
    Scott, Charlie
    Kolkhof, Peter
    Lawatscheck, Robert
    Wang, Lili
    Joseph, Amer
    Pitt, Bertram
    AMERICAN JOURNAL OF NEPHROLOGY, 2023, 54 (9-10) : 370 - 378
  • [47] Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes
    Viazzi, Francesca
    Piscitelli, Pamela
    Giorda, Carlo
    Ceriello, Antonio
    Genovese, Stefano
    Russo, Giuseppina T.
    Fioretto, Paola
    Guida, Pietro
    De Cosmo, Salvatore
    Pontremoli, Roberto
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (02) : 419 - 426
  • [48] Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25)
    Yokoyama, H.
    Araki, S.
    Haneda, M.
    Matsushima, M.
    Kawai, K.
    Hirao, K.
    Oishi, M.
    Sugimoto, K.
    Sone, H.
    Maegawa, H.
    Kashiwagi, A.
    DIABETOLOGIA, 2012, 55 (07) : 1911 - 1918
  • [49] The potential role of finerenone in patients with type 1 diabetes and chronic kidney disease
    Vasco, Maria Adelaida Escobar
    Fantaye, Samuel H.
    Raghunathan, Sapna
    Solis-Herrera, Carolina
    DIABETES OBESITY & METABOLISM, 2024, 26 (10) : 4135 - 4146
  • [50] Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes
    DeFronzo, Ralph A.
    Bakris, George L.
    DIABETES OBESITY & METABOLISM, 2022, 24 (07) : 1197 - 1205
12345